CGEM
CULLINAN THERAPEUTICS INCData as of 2026 Q2 (06-30) · 13F snapshot
Summary
CULLINAN THERAPEUTICS INC (CGEM) is held as common stock by 5 tracked hedge-fund managers, with a combined reported value of ~$21.27M; the largest are Ken Griffin, Izzy Englander, Renaissance Technologies. 2 tracked managers also disclosed PUT or CALL positions, reported separately below. This quarter: 2 added, 2 trimmed. Data as of 2026 Q2, from public SEC 13F filings, delayed up to ~45 days.
Attention · MediumThis quarter · Mixed
Common-stock holders52 also report options
Congress trades0
Price$15.23vs quarter-end-16.36%
Sectors0
This quarter's moves
Top holderNew0
Added2
Trimmed / sold2
Ken GriffinCommon-stock positions
PUT and CALL disclosures are excluded from these holder counts and values.
Izzy EnglanderHold
Value $6.30M0.0% of portfolio346,2322026 Q2
| Investor | Value | % of portfolio | Action |
|---|---|---|---|
| Izzy Englander | $6.30M | 0.0% | Hold |
PUT / CALL disclosures
Reported separately: 13F option values are not common-stock ownership and do not reveal the full strategy or economic exposure.
Value $1.19M— of portfolio65,2002026 Q2
Value $919.6K— of portfolio50,5002026 Q2
Value $364.2K— of portfolio20,0002026 Q2
| Investor | Value | % of portfolio | Action |
|---|---|---|---|
| Ken GriffinPUT | $1.19M | — | — |
| Ken GriffinCALL | $919.6K | — | — |
| Izzy EnglanderCALL | $364.2K | — | — |
Public SEC 13F filings may appear up to 45 days after quarter-end; STOCK Act / OGE trade filings are generally due within 45 days but may be late. Partial data only — research, not investment advice.